Dianthus Therapeutics Banner

SEC Filing Details

Dianthus Therapeutics Highlights Recent Business Achievements and Reports Q3 Financial Results

Document Details

Form
Filing Date
Sep 13, 2023
Document Date
Sep 11, 2023
Form Description
Initial filing by director officer or owner of more than ten percent.
Filing Group
3,4,5
Company
Dianthus Therapeutics
Issuer
DIANTHUS THERAPEUTICS, INC. /DE/
Filer
Fairmount Funds Management LLC